MedicarePartD.guide

A non-government resource built from CMS public data

SGLT2 inhibitors on every 2026 Indiana Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Indiana cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
SGLT2 inhibitors by 2026 Indiana Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-138Wellcare Value Script$8.60/moS4802-150Wellcare Classic$8.70/moS4802-086Humana Value Rx Plan$9.90/moS5884-194SilverScript Choice$29.70/moS5601-030HealthSpring Extra Rx$78.20/moS5617-365AARP Medicare Rx Saver from UHC$90.30/moS5921-360HealthSpring Assurance Rx$117.80/moS5617-222Humana Premier Rx Plan$125.30/moS5884-161AARP Medicare Rx Preferred from UHC$127.10/moS5921-396
JardianceempagliflozinTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 319%QL 30/30dTier 317%QL 30/30dTier 317%QL 30/30dTier 320%QL 30/30dTier 3$45.00QL 30/30dTier 318%QL 30/30d
FarxigadapagliflozinTier 325%QL 30/30dNot coveredNot coveredTier 320%QL 30/30dTier 319%QL 30/30dTier 317%QL 30/30dNot coveredTier 320%QL 30/30dTier 3$45.00QL 30/30dNot covered
dapagliflozingeneric FarxigaTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 319%QL 30/30dTier 317%QL 30/30dTier 317%QL 30/30dTier 320%QL 30/30dTier 3$45.00QL 30/30dTier 318%QL 30/30d
InvokanacanagliflozinNot coveredTier 440%QL 60/30dTier 427%QL 60/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
SteglatroertugliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
InpefasotagliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.